The gynecological devices market has seen considerable growth due to a variety of factors.
• The market for gynecological devices has seen robust growth in recent years. It is projected to expand from $13.16 billion in 2024 to $14.18 billion in 2025, maintaining a compound annual growth rate (CAGR) of 7.8%. The historical growth trends are predominantly due to the advent of laparoscopic surgery, developments in intrauterine devices (IUDs), the evolution of hysteroscopy, the emergence of robotic surgery, and advancements in diagnostic imaging.
The Gynecological Devices market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the gynecological devices market is predicted to experience a substantial growth spurt. With a compound annual growth rate (CAGR) of 9.1%.
, it is projected to reach $20.09 billion in 2029. Factors contributing to this robust growth during the forecast period include an increase in spending on women's healthcare, advancements in robotic surgery, tailored treatment approaches, and rapid expansion of ambulatory surgical centers. The forecast period is also expected to see a trend towards less invasive procedures, a move towards ambulatory settings, increased emphasis on women's health awareness, patient-focused strategies, and investment in research and development.
The escalation in gynecological disorders is predicted to stimulate the expansion of the gynecology devices market. Gynecological disorders, which are ailments that disrupt the typical function of female reproductive organs like the breasts and abdominal and pelvic organs, are increasingly common. Devices utilized in gynecology manage the female reproductive system, including pregnancy and childbirth and are also involved in a range of medical procedures such as colposcopy, loop electrical excision procedure (LEEP), endometrial biopsy, IUD insertion, dilation and curettage (D&C), tubal ligation, ovarian cystectomy, and more. For example, in March 2023, the World Health Organization (WHO), a Switzerland-based intergovernmental agency, reported that endometriosis impacts approximately 190 million women and girls in their reproductive age globally. Furthermore, the American Cancer Society, a US-based charity, published a report in January 2023 stating an expected 13,960 new instances of invasive cervical cancer to be diagnosed in 2023, with about 4,310 women anticipated to succumb to cervical cancer in the same year. Consequently, the rising frequency of gynecological disorders is contributing to the enlargement of the gynecological devices market.
The gynecological devices market covered in this report is segmented –
1) By Device: Surgical Devices, Diagnostic Imaging Systems, Hand Held Instruments, Software, Other Devices
2) By Application: Laparoscopy, Hysteroscopy, Dilation And Curettage, Colposcopy, Other Applications
3) By End User: Clinics, Hospitals, Diagnostic Centers, Research Institutes, Others End Users
Subsegments:
1) By Surgical Devices: Hysteroscopes, Laparoscopes, Endometrial Ablation Devices, Biopsy Forceps
2) By Diagnostic Imaging Systems: Ultrasound Machines, MRI Systems, CT Scanners, X-ray Systems
3) By Hand Held Instruments: Speculums, Forceps, Scissors, Scalpels
4) By Software: Electronic Medical Records (EMR) Software, Imaging Software, Data Management Software
5) By Other Devices: Contraceptive Devices, Menstrual Cups, Pelvic Floor Devices
A leading trend observed in the gynecological devices market is the influence of technological advancements. To stay competitive in the market, companies in this sector are rapidly embracing latest technologies. For example, in February 2023, Boston Imaging (Samsung), a leading US provider of medical imaging technology, unveiled the Hera W10 Elite. This system, equipped with artificial intelligence capabilities, provides a breakthrough in women's health ultrasound. It enables visualization of microcirculatory and slow-moving blood in both 2D and 3D. The Hera W10 Elite also features an advanced MV-flow functionality and a larger organic light-emitting diode (OLED) for enhanced interpretation of various ultrasound imagines used in obstetric and gynecological procedures, thereby offering clinicians improved insights for diagnosis. Moreover, included in the system is a pioneering transducer for endovaginal visualization of the fetus' heart and brain. Enhanced AI components of the system include features like HeartAssist, ViewAssist, and BiometryAssist.
Major companies operating in the gynecological devices market include:
• Medtronic plc
• CooperSurgical Inc.
• Richard Wolf GmbH
• Hologic Inc.
• Boston Scientific Corporation
• Stryker Corporation
• Karl Storz SE & Co. KG
• Ethicon Inc.
• MedGyn Products Inc.
• General Electric Company
• Gynex Corporation
• Bayer AG
• Gynemed Medizinprodukte GmbH & Co. KG
• Meril Life Sciences Pvt. Ltd.
• Cook Group Inc.
• B. Braun Melsungen AG
• Siemens Healthineers AG
• Smith & Nephew plc
• Steris Corporation
• Abbott Laboratories
• Fujifilm Holdings Corporation
• Koninklijke Philips N.V.
• Medline Industries Inc.
• Mindray Medical International Limited
• Olympus Medical Systems Corporation
• Cardinal Health Inc.
North America was the largest region in the gynecological devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gynecological devices market report forecast period. The regions covered in the gynecological devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa